[Anticholinesterase agents and axial teratogenesis in quail embryos]

R Meiniel1

  • 1Laboratoire de Biologie animale, Université Clermont-Ferrand II E.R.A. au C.N.R.S. no 408, B.P. 45, F-63170, Aubière, France.

Insights

Cholinesterase inhibition in Japanese quail embryos by organophosphates and carbamates is linked to spine anomalies. However, specific malformations like beak and leg defects were not associated with this enzyme inhibition.

Area of Science:

  • Toxicology
  • Developmental Biology
  • Neuroscience

Context:

  • Investigating the teratogenic effects of chemical compounds on embryonic development.
  • Examining the mechanism of action of organophosphorous (OP) and carbamate (C) compounds on enzyme activity.

Purpose:

  • To determine the relationship between cholinesterase inhibition and the induction of spinal anomalies in Japanese quail embryos.
  • To differentiate between teratogenic effects directly linked to cholinesterase inhibition and those caused by other mechanisms.

Summary:

  • Organophosphorous (OP) and carbamate (C) compounds were tested for their effects on Japanese quail embryos and cholinesterase activity.
  • In vitro studies showed embryonic cholinesterases are sensitive to carbamates; in vivo, spine anomalies correlated with cholinesterase inhibition by most tested compounds.
  • Malathion (OP) and ambenonium (GO) were embryotoxic but not teratogenic, and showed little cholinesterase inhibition. Beak/leg malformations were not linked to cholinesterase inhibition.

Impact:

  • Confirms a strong link between cholinesterase inhibition and axial abnormalities in developing quail embryos.
  • Highlights that not all chemical-induced embryotoxicity or teratogenicity is mediated by cholinesterase inhibition.
  • Provides insights into the specific mechanisms of teratogenesis for different classes of chemical agents.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.8K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.7K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.9K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K